More Information on 'Synthego'

Synthego is a biotechnology company that provides CRISPR solutions for life science research, molecular biology, and diagnostic workflows. The company offers a range of products, including research-grade and GMP-grade CRISPR enzymes, such as SpCas9 and AccuBase, as well as single-guide RNA (sgRNA) for various applications, including gene editing and gene therapy. Synthego's products are designed to support the development of cell and gene therapies, from early discovery to clinical trials, and the company provides regulatory expertise and support to help customers navigate the transition from research to clinical applications. Additionally, Synthego offers molecular diagnostics products, including isothermal amplification and PCR enzymes, to support the development of point-of-care diagnostics and other molecular diagnostic applications.

About Synthego
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s platform technologies vertically integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance basic research, target validation, and clinical trials. With its technologies cited in hundreds of peer-reviewed publications and utilized by thousands of commercial and academic researchers and therapeutic drug developers, Synthego is at the forefront of innovation enabling the next generation of medicines by delivering genome editing at an unprecedented scale.